Stoked Bio Inc.
PrivateLast Round
Seed
May 1, 2026
Total Funding Raised
$2.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Stoked Bio Inc. is a biotechnology company that develops new candidates for resistant infectious diseases and cancers identified using a biology-driven, AI-assisted drug discovery and optimization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stoked Bio Inc. Comparables
Compare Stoked Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ArrePath | 80% | |
| Genesis Molecular AI | 78% | |
| Phare Bio | 77% | |
Stoked Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 3709% MoM, reaching 1.3K.
- Mar 4, 2026
Monthly visitors grew 33% MoM, reaching 1.6K.
Stoked Bio Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stoked Bio Inc.'s valuation, stock price, and market status.